Fat Burners

T3 (Liothyronine Sodium) 0,025 mg Hilma Biocare

Hilma Biocare

30,00

In Stock (100 available)

T3 (Liothyronine Sodium) 0,025 mg Hilma Biocare (0,025 mg) — Hilma Biocare presents this pharmaceutical-grade compound — the most active thyroid hormone and the most potent fat-burning agen…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

T3 (Liothyronine Sodium) 0,025 mg Hilma Biocare — liothyronine (T3) from Hilma Biocare at 0.025 mg. Active thyroid hormone bypassing T4-to-T3 conversion. Increases metabolic rate, fatty-acid oxidation, and protein turnover.

Key Benefits

  • Synthetic thyroid hormone — overrides metabolic rate
  • Pair with testosterone to prevent muscle catabolism
  • Taper up from 25 mcg, taper down at cycle end
  • Monitor TSH, free T3/T4 before and during
  • Aggressive fat-burner — harsh on cardiovascular system
  • Each unit dosed at 025 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: start 25 mcg/day, titrate by 12.5 mcg every 5–7 days to 50–75 mcg/day. Taper down similarly at end — do not stop cold. Cycles 6–8 weeks.

How It Works

Liothyronine, synthetic triiodothyronine (T3). Exogenous T3 suppresses TSH and shuts down endogenous thyroid output — taper critical to avoid hypothyroid rebound. Aggressively raises metabolic rate; catabolic to muscle without anabolic support.

Pharmacokinetics

Plasma half-life approximately 1–2 days. Once-daily dosing. Steady-state in 7 days. Endogenous thyroid suppression develops within a week.

Potential Side Effects

Tachycardia, sweating, insomnia, irritability. Muscle catabolism without anabolic support. TSH crashes — TFTs before starting, during, and 4 weeks after. Cardiovascular stress significant.

Cycle & Stacking Guide

6–8 weeks within an aggressive cut, always with testosterone base (150–200 mg/week minimum) to prevent muscle loss. Stack with clenbuterol for synergy. Not a standalone fat-burner.

Manufacturer Notes

Hilma Biocare operates a Romanian GMP site with dedicated HPLC bays. Their catalogue emphasises clean oil carriers (often MCT or ethyl oleate) to reduce post-injection pain.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “T3 (Liothyronine Sodium) 0,025 mg Hilma Biocare”

Your email address will not be published. Required fields are marked *

Liothyronine

Physical & Chemical Properties for Research Purposes
Chemical structure of Liothyronine (C15H12I3NO4) for laboratory analysis
2D structural representation · PubChem CID 5920 ↗
Chemical Identity
# CAS Registry Number 6893-02-3
Σ IUPAC Name (S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid
F Molecular Formula C15H12I3NO4
M Molecular Weight 650.97 g/mol
SMILES N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
InChIKey AUYYCJSJGJYCDS-LBPRGKRZSA-N
Melting Point 236-237 (decomposition) °C
Solubility Very slightly soluble in water; soluble in dilute NaOH
Biological Half-life 2.5 days (oral)
PubChem CID 5920 ↗
Pharmacological Profile
Aromatization None
Hepatotoxicity None
Known trade names: Cytomel, Triostat, Thybon

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.